Boston Scientific to buy medical technology company Relievant Medsystems for $850m
Boston Scientific Corporation has struck a definitive deal to purchase Relievant Medsystems for an upfront payment of $850 million. Additional undisclosed contingent payments are also agreed upon based on Relievant Medsystems’ sales performance over the next three years. FDA-Approved Intracept System a Game-Changer for Vertebrogenic Pain The acquisition includes the Intracept Intraosseous Nerve Ablation System, […]